Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years

Mohsen S. Elalfy, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohamed Badr, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Caroline Fradette, Anna Rozova, Noemi Toiber Temin, Fernando Tricta, Janet L. Kwiatkowski

Blood Adv (2023) 7 (4): 611–619.

https://doi.org/10.1182/bloodadvances.2021006778

Published: 2023

Includes: Supplemental data

Journal Articles

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study

Janet L. Kwiatkowski, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohammed Badr, Abdulrahman Alshehri, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Fernando Tricta, Mohsen S. Elalfy

Blood Adv (2022) 6 (4): 1243–1254.

https://doi.org/10.1182/bloodadvances.2021004938

Published: 2022

Includes: Supplemental data

Journal Articles

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support

Stella T. Chou, Mouaz Alsawas, Ross M. Fasano, Joshua J. Field, Jeanne E. Hendrickson, Jo Howard, Michelle Kameka, Janet L. Kwiatkowski, France Pirenne, Patricia A. Shi, Sean R. Stowell, Swee Lay Thein, Connie M. Westhoff, Trisha E. Wong, Elie A. Akl

Blood Adv (2020) 4 (2): 327–355.

https://doi.org/10.1182/bloodadvances.2019001143

Published: 2020

Includes: Supplemental data